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Progression of renal insufficiency: Role of blood pressure. The effect of
blood pressure on progression of renal insufficiency was examined in a
large group of patients who eventually required dialysis. Out of 198
consecutive new chronic dialysis patients, 86 had sufficient data predi-
alysis to determine rates of progression of renal insufficiency by
reciprocal creatinine versus time plots. Average plasma creatinine at
first contact was 3.8 0.2 mg/dl and at the time of dialysis was 11.4
0.4 mgldl. Mean duration of follow-up was 33.4 2.5 months and the
average rate of decline in reciprocal creatinine was —0.009 0.001 dl!
mg month. Patients were stratified by average value of diastolic blood
pressure measured in clinic. Patients in the lowest quartile had a rate of
decline in reciprocal creatinine of —0.007 0.001 dl/mg month, which
was slower than that of patients in the third and fourth quartiles, —0.010
0.001 and —0.011 —0.002 dl/mg month, respectively (P <0.05). In
individual patients, a mean diastolic BP of <90 mm Hg was associated
with a rate of decline in reciprocal creatinine of —0.006 0.001 dl!mg
month which was significantly less than the rate of —0.009 0.001
when the diastolic BP was >90 mm Hg. Thus, in a large group of
patients who have progressed to ESRD, there is an association between
control of diastolic blood pressure and a slower rate of decline in renal
function.
The natural course of renal insufficiency from any cause
appears to be progression over time to end-stage renal disease
(ESRD) [1,21. In animal models where renal insufficiency
progresses to end stage disease in months, the progression can
be delayed by therapeutic interventions, such as restriction of
dietary protein [3], phosphorus depletion [4] and reduction in
systemic and/or intrarenal arterial blood pressure [5,6]. Clinical
studies employing a low protein diet with or without supple-
mental amino acids or their keto acid analogues have confirmed
this beneficial effect in patients with renal disease [7,81. The
clinical value of reductions in systemic blood pressure have not
been demonstrated in large grdups of patients with renal disease
from a variety of causes. The purpose of this retrospective,
longitudinal study was to determine if there was any apprecia-
ble effect of treatment with antihypertensive drugs on the rate
of progression of renal insufficiency in a large cohort of patients
who ultimately developed ESRD. The data from 86 such
patients indicate that control of diastolic blood pressure to an
average value of less than 90 mm Hg was associated with a
slower rate of decline in renal function.
Methods
Data from patients seen and followed by the Nephrology
Section of the Durham VAMC have been kept on a computer-
ized medical record since January, 1979 [9]. From this data-
base, we identified all patients who started dialysis therapy at
the Durham VA Medical Center between January 1, 1982 and
December 31, 1987. The list included patients with acute renal
failure (reversible disease or renal failure as a complication of
another illness) and chronic renal failure. For the patients with
chronic renal failure, we reviewed the computerized medical
records to determine when they were first seen by the Nephrol-
ogy Section, duration of follow-up until dialysis, rate of decline
in renal function (a plot of reciprocal plasma creatinine versus
time), blood pressure measured at clinic visits, and prescribed
medications.
The change in renal function was estimated by the slope of
the reciprocal of plasma creatinine versus time plot. The
minimum criteria for this plot were four measurements of
plasma creatinine during a time period that was at least six
months. The average number of data points per patient was 16
(±8 SD). We used the reciprocal creatinine versus time plots in
this study because that was the only quantitative measure of
renal function available retrospectively on this patient popula-
tion. To minimize potential problems with this approach, we
examined patients' records for changes in dry weight that might
affect rates of creatinine production. The dry weight of patients
averaged 79.0 16.3 kg (standard deviation) and did not change
significantly during the time course of this study.
Results
The patient population
In the six year period between January 1, 1982 and December
31, 1987, 358 patients began dialysis therapy at the Durham VA
Medical Center. Patients were considered to have acute renal
failure if they recovered renal function or if renal failure was
part of a terminal illness associated with the failure of multiple
organs. One hundred sixty patients were in this category. These
patients were not considered in the remainder of the study.
The remaining 198 patients started maintenance dialysis for
chronic renal failure during this time interval. In reviewing their
records, we identified 112 patients who were dialyzed within six
months of first contact with the VA Nephrology Section. This
time period was inadequate for determining the rate of progres-
sion of renal disease or the efficacy of a therapeutic interven-
tion. These patients comprise 56% of new chronic dialysis
patients in this medical center. This finding suggests that a large
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Table 1. Antihypertensive medications
Use
Medication % of patients
Furosemide 94
Beta blockers 50
Prazosin 50
Clonidine 34
Hydralazine 26
Minoxidil 19
Calcium channel blockers 12
Methyldopa . 3
Guanethidine 2
Captopril' 2
percentage of patients who develop ESRD are not referred to a
medical center until very late in the course of their disease.
Some of these patients did not seek medical care until late in the
disease; others were followed by a primary care physician prior
to referral.
The remaining 86 patients had sufficient predialysis data to
evaluate the effect of blood pressure control on the progression
of renal insufficiency. These patients consisted of 84 men and 2
women. Forty-four of them were Black, 40 White, I Oriental
and I Hispanic American. Their average value of plasma
creatinine at first contact with the Nephrology Section was 3.8
mg/dl (range of 1.1 to 8.6 mgldl). The average creatinine value
at the start of dialysis was 11.4 mg/dl (range of 5.0 to 22.0 mg/
dl). The mean duration of pre-dialysis follow-up was 33.4
months (range 6.8 to 111.2 months). Their age at the time of
dialysis was 55.4 years (range 25.0 to 75.5 years). The cause of
progressive renal failure was identified from the patient's prob-
lem list. The frequency of specific diagnoses were as follows:
diabetes mellitus in 30%, glomerulonephritis in 24%, interstitial
nephritis associated with urinary tract obstruction, stones or
infection in 12%, polycystic kidney disease in 3%, multiple
myeloma in 3%, rejection of renal transplant in 3%, systemic
diseases with renal involvement in 3%, and unknown in 22%.
Hypertension was present on the problem list in 80% of these
patients.
In this population 95% of patients were treated with antihy-
pertensives prior to onset of dialysis. The drugs prescribed and
the percentage of patients who were given them are indicated
on Table 1. The use of angiotensin converting enzyme inhibitors
and calcium channel blockers was limited because much of the
time course of this study predates their generalized use for the
treatment of hypertension. Phosphate binders were prescribed
for 73% of the patients prior to dialysis. The usual starting dose
of aluminum hydroxide was 500 to 1000mg with meals. Most of
the patients were instructed in a relatively low protein (0.6 g/kg/
day plus replacement of losses due to proteinuria), low sodium
(2 g/day) diet. Patient compliance with prescribed medications
or diet was not assessed directly.
The change in renal function was estimated by the slope of
the reciprocal of the plasma creatinine versus time plot. The
data from these plots were usually well described by a single
line. The R values for linear regression analyses were greater
than 0.8 in 90% of the cases and were less than 0.5 in only four
cases (5%). The data did not fit a second order function as well
as a linear function. As a group the average slope in the
reciprocal plasma creatinine plots was —0.0090 0.0007 (SE)
mi/mg month. This rate of decline is approximately equivalent
to a reduction in glomerular filtration rate of —0.9 mI/mm!
month, if we assume that the glomerular filtration rate is 100 ml!
mm when the plasma creatinine is 1.0 mg/dl.
Effect of blood pressure
The systolic and diastolic blood pressures taken in the sitting
position in renal clinic were averaged for each patient. To
determine if there was an effect of blood pressure on the overall
rate of decline of the reciprocal plasma creatinine, we stratified
the patients according to their diastolic blood pressures. The
average rate of decline in the reciprocal plasma creatinine for
each quartile of patients is shown in Figure 1A. The quartile of
patients with the lowest diastolic blood pressures had mean
diastolic pressure of 80 I (SE) mm Hg and an average rate of
decline of —0.0071 0.0010 dl!mg month. The second quartile
had average diastolic blood pressure of 88 1 mm Hg and a rate
of decline that was not different from the lowest quartile. The
third and fourth quartiles had mean diastolic blood pressures of
93 I and 101 1 mm Hg, respectively, and had significantly
faster rates of decline in reciprocal creatinine, —0.0105
0.0015 and —0.0108 0.0015 dl!mg month, respectively, than
that of patients in the lowest quartile (P < 0.05 by unpaired
t-test). The rate of decline of the second quartile was signifi-
cantly lower than that of the fourth quartile (P < 0.05) but was
not significantly different from that of the third quartile (P <
0.10). Thus, in this general population of patients with chronic
renal failure, higher levels of diastolic blood pressure were
associated with a more rapid rate of progression to ESRD.
The data from patients in each quartile was examined to
determine if there was a predilection for a specific diagnosis or
antihypertensive treatment. The patients with diabetes mellitus
or glomerulonephritis were distributed equally among the quar-
tiles of diastolic blood pressure. Antihypertensive medications
were prescribed by several physicians according to their pref-
erence. The frequency of their use was dispersed among the
quartiles of diastolic blood pressure. We examined the slope of
the reciprocal creatinine versus time plot for patients on each
medication and found no significant differences. Thus, there
was no identifiable association of diagnosis or medication with
any of the quartiles of diastolic blood pressure.
When the data were stratified for mean systolic blood pres-
sure, there were no significant differences between the rate of
decline of reciprocal creatinine between groups (Fig. IB). The
rate of decline averaged —0.0079 0.0012 dl!mg month for the
lowest quartile of systolic blood pressure whose average sys-
tolic pressure was 132 1 mm Hg. The highest quartile had a
mean systolic blood pressure of 181 2 mm Hg and an average
rate of decline in renal function of —0.0088 0.0013 dl/mg
month.
Characterization of baseline values
Next we asked the question, is the rate of progression of renal
insufficiency the same over time or does the rate increase or
decrease as renal function deteriorates. To evaluate this possi-
bility we divided the reciprocal creatinine versus time plots into
arbitrary one year segments for up to five years of follow-up and
compared the slopes of adjacent segments by a paired t-test. In
this analysis we found some variation in the slope of the
reciprocal creatinine versus time plot year to year in individual
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patients even though the whole plot closely followed a single
line. In these patients as a group, however, there was no
significant trend for the slope to become more or less negative
during the follow-up time. Thus, in this population of patients,
the rate of progression of renal insufficiency did not change
during five years of follow-up.
Next we examined the data to determine if the slope of
reciprocal creatinine versus time plot changed as the plasma
creatinine increased. For each patient, the slope of the recip-
rocal creatinine versus time plot was calculated for the follow-
ing three intervals of plasma creatinine: values from 1.5 to 3.0
mg/dI, from 3.1 to 6.0 and from 6.1 to 12. The slopes from
subsequent intervals in each patient were compared with a
paired t-test. Again, there were often changes in the slope of an
individual case from one interval to the next, but these changes
were just as likely to occur in either direction. The mean paired
differences in these slopes indicate no significant difference in
the slope as the plasma creatinine increases within the range of
1.5 to 12 mg/dl. Thus, the slope of the reciprocal creatinine
versus time plot was not affected by the level of plasma
creatinine.
Effect ofchange in blood pressure in individual patients
The slope of the reciprocal creatinine versus time plot does
not change as a function of time or plasma creatinine; does it
change with an alteration in the level of diastolic blood pres-
sure? To address this question, we identified nineteen patients
(six with diabetes mellius) who had adjacent time periods when
their diastolic blood pressure was consistently above 90 mm Hg
and when it was below 90 mm Hg. The slope of the reciprocal
creatinine versus time for both time periods was determined in
each individual and the data were compared by a paired t-test.
In 14 cases the direction of the change in blood pressure was a
reduction and in five cases an elevation. Figure 2 shows mean
values for the slope when diastolic blood pressure was con-
trolled and when it was >90 mm Hg. The average value of the
diastolic blood pressure was 97 2 mm Hg for the hypertensive
time period and 84 1 mm Hg for the normotensive time
interval. The hypertensive time interval was associated with a
significantly faster rate of decline in reciprocal creatinine than
the normotensive interval (P <0.005). These data indicate that
in a single patient an average diastolic blood pressure less than
90 mm Hg is associated with a slower rate of progression to
ESRD.
Discussion
The purpose of this retrospective study was to review sys-
tematically our previous experience with patients who pro-
_________________________________________
gressed to ESRD and from that experience to determine those
factors which were associated with an amelioration of the rate
of progression. The results of this study should provide an
hypothesis or a reasonable basis for prospective studies which
will determine, more directly, the role of these factors in
progressive renal disease. The factor which we examined was
control of blood pressure. The data indicate an association
between control of diastolic blood pressure to values less than
90 mm Hg and a slower rate of progression to renal failure.
Use of the reciprocal plasma creatinine versus time plot as an
indication of changes in glomerular filtration rate (GFR) is
controversial. It has been used as a simple method for following
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Fig. 1. A. Relationship of rate of decline in renal function to diastolic
blood pressure. Patients were stratified into quartiles by mean diastolic
blood pressure. Range of diastolic blood pressures for each quartile is
indicated on X axis. Bars represent mean + SE of slope from reciprocal
creatinine versus time plot for 21 patients. Statistical comparisons
between quartiles were made using an unpaired t-test and are given in
the text. B. Relationship of rate of decline in renal function to systolic
blood pressure. Range of systolic blood pressures for each quartile is
indicated on X axis.
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FIg. 2. Effect of diastolic blood pressure on rates of decline in renal
function in individual patients. Bars represent mean + SE of slope from
reciprocal creatinine versus time plot determined at times when their
diastolic blood pressure was >90 mm Hg and again when it was <90
mm Hg. N equals 19 patients. Statistical comparison between slopes
was made using a paired t-test and * indicates P < 0.05.
or estimating the rate of progression of renal insufficiency
[7,10,11]. However, this mathematical transformation has not
always been useful. Gretz, Manz and Strauch [12] reported that
reciprocal creatinine data from early time points was a poor
predictor of when dialysis will occur. In patients with severe
renal insufficiency (GFR less than 16 mI/mm) the slope of the
reciprocal creatinine versus time plot significantly underesti-
mated the change in glomerular filtration rate as measured by
radiolabelled EDTA clearances [13]. The inaccuracy of the
reciprocal creatinine estimate of GFR is related to the observa-
tion that creatinine clearances and inulin clearances differ in
patients with renal insufficiency [14]. Creatinine clearances
were generally greater than inulin clearances, but there was no
constant relationship between these clearances over a wide
range of renal function (mild to severe reductions in GFR) [14].
We used the reciprocal creatinine versus time plots in this study
because that was the only quantitative measure of renal func-
tion available retrospectively on this patient population. To
minimize the problems mentioned above, we selected patients
who had completed their progression to ESRD and did exten-
sive analyses to identify possible effects of follow-up time or
level of plasma creatinine on this plot (Results). These analyses
confirm the linearity of the slope of the reciprocal creatinine
versus time plots for the patient data being studied. With these
constraints in mind, we used the slope of the reciprocal plasma
creatinine versus time plot as an estimate of changes in renal
function.
An association between control of diastolic blood pressure
and progression of renal disease has been shown in animal
models of renal disease. In the subtotal ablation model of renal
disease in rats, the reduction in GFR and incidence of glomer-
ular sclerosis can be ameliorated by a variety of maneuvers
such as administration of anticoagulants [15,16], thromboxane
synthetase inhibitors [5] or angiotensin converting enzyme
inhibitors [6,17]. In each of these maneuvers there was a
significant reduction in systemic blood pressure which may
have contributed, in part, to preservation of function. Hyper-
tension has also been implicated in the progression of renal
disease in the nephrotoxic serum nephritis model of renal injury
in rats. Baldwin and coworkers showed that antihypertensive
treatment in this disease reduces the glomerular lesions and
proteinuria [18] and conversely, that superimposing hyperten-
sion with a renal vascular clip enhanced the glomerular lesions
[19]. Thus, in two animal models of renal disease, hypertension
may be one of the factors causing progression of dysfunction.
In patients with renal disease the role of hypertension in the
progression of disease is less clear, Two studies have shown
that control of blood pressure reduced the rate of progression of
renal insufficiency in a small number of patients with insulin-
dependent diabetes mellitus and diabetic nephropathy [20,21].
In these studies with 6 and 10 patients, mean values of blood
pressure were reduced from 162/103 and 144/97 mm Hg to 144/
95 and 128/84, respectively, and the rate of decline in GFR was
reduced to 40% of the baseline value. This positive finding was
not confirmed in a larger study by Oldrizzi, Rugiu and Maschio
examining the association of hypertension and progression of
renal insufficiency in patients on a protein-restricted diet [22].
In their study 113 patients on a low-protein diet for an average
of 51 months were stratified by mean arterial pressure. The
monthly rate of increase in plasma creatinine was not affected
by level of blood pressure. These authors concluded that many
factors other than hypertension might have influenced the
progression of renal insufficiency in this population. Bergstrom
et al [11] reported that control of diastolic blood pressure to an
average value of 90 mm Hg in 17 patients with renal insuffi-
ciency was associated with a 50% reduction in their rate of
decline of the reciprocal plasma creatinine. Thus, studies which
report a positive effect of blood pressure control in ameliorating
the progression of renal disease are limited in number of
patients or type of renal disease, that is insulin-dependent
diabetes mellitus. Studies with a large number of patients and a
variety of renal diseases have been unable to show a role for
hypertension in the progression of clinical renal disease.
In comparison to previous studies, our data examined a
relatively large number of patients. We screened data on all
patients who started chronic dialysis at our medical center
during a six year interval and selected those who were followed
long enough prior to dialysis to provide information regarding
their rate of decline in function. Our patient population may be
somewhat unique in that it is 50% Black and has a very high
incidence of hypertension. Data from the entire time of fol-
low-up indicated an association between control of diastolic
blood pressure and slower rates of progression to ESRD (Fig.
1). This result is similar to that of Bergstrom et al [11]. The same
relationship did not occur for mean values of systolic blood
pressure, which may explain negative results of Oldrizzi et al
[22], who stratified patients by mean arterial pressure. The
relationship between diastolic blood pressure and rate of de-
cline in renal function was confirmed in our study by the
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demonstration that in individual patients reduction of mean
diastolic blood pressure from hypertensive range to values less
than 90 mm Hg was associated with a significant reduction in
the rate of progression to ESRD (Fig. 2). The rate of progres-
sion was reduced by 33%, a value similar to that observed by
Mogensen [20] and Parving et at [21] in patients with diabetic
nephropathy. Thus, the present study extends previous obser-
vations by showing the association of diastolic hypertension
and progression of renal insufficiency in a large population of
patients with a variety of renal diseases. Additionally, the data
indicate that control of diastolic hypertension may slow the rate
of progression of renal insufficiency in a general population of
renal patients.
Thus, this retrospective study of all patients who progressed
to dialysis at the Durham VA Medical Center indicates that the
reciprocal creatinine versus time plot is linear in the majority of
patients; that control of diastolic blood pressure to values less
than 90 mm Hg is associated with a slower rate of progression
toward ESRD. These data indicate that control of diastolic
hypertension in patients with renal insufficiency is a potentially
effective way to slow the progression toward ESRD. On the
basis of these data, future studies should prospectively examine
the effectiveness of specific antihypertensive agents like the
angiotensin converting enzyme inhibitors.
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